Welcome

At Kid Risk, we focus on improving children's lives by understanding, characterizing, and communicating about the real risks that children face around the world, and on empowering policy makers, parents, kids, and others to use the best available information and analytical insights as we do our best for children. We recognize that managing risks is the key to realizing the best possible futures for everyone. Learn more about our mission and organization and meet our team.

Kid Risk currently focuses its research on managing the risks associated with polioviruses (read an overview) and characterizing the benefits of global investments in measles and rubella immunization. We receive funding for our research from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the Bill & Melinda Gates Foundation. Our research demonstrates that investments in public health save lives and money.

News August 11, 2017 - Read an editorial by Dr. Thompson that asks: "What will it take to end human suffering from measles?" Read the July 27 press release announcing a special issue of Risk Analysis on modeling and managing the global risks of measles and rubella, and listen to the related webinar.

July 2017 - In collaboration with the Global Polio Eradication Initiative (GPEI), Kid Risk launched a survey of the Global Polio Laboratory Network (GPLN) that requests information from all GPLN laboratories by September 1, 2017.

July 2017 - Read about our extensive research on polio and our recent analyses that reflect on lessons learned from (i) overcoming the failure to vaccinate and the role of subpopulations and (ii) globally-coordinated cessation of serotype 2 oral poliovirus vaccine, systematically review the published literature on poliovirus environmental surveillance, model the benefits of temporary recommendations for travel immunization requirements for serotype 1 wild polioviruses, model poliovirus vaccine supply and stockpile dynamics during the endgame, characterize the costs and benefits of using IPV in addition to OPV for outbreak response, and highlight the importance of remaining prepared and managing the poliovirus endgame risks. You can also check out our other news and learn more about our research.

Join our mailing list to receive press releases and/or periodic updates about our work. Thank you to all of our supporters.